BeyondSpring Inc [BYSI] stock is trading at $3.57, down -1.65%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BYSI shares have gain 19.80% over the last week, with a monthly amount glided 176.74%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 25, March 2024, BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer. In a post published today on Yahoo Finance, BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that the first patient has been dosed in a Phase 2 investigator-initiated trial (IIT) with Pembrolizumab, Plinabulin, BeyondSpring’s lead asset, plus Etoposide/Platinum (EP) for first-line (1L) Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) [NCT05745350].
From an analyst’s perspective:
BeyondSpring Inc [NASDAQ: BYSI] stock has seen the most recent analyst activity on December 02, 2021, when Jefferies downgraded its rating to a Hold and also revised its price target to $5 from $38. Previously, BofA Securities downgraded its rating to Underperform on December 02, 2021, and dropped its price target to $5. On December 01, 2021, downgrade downgraded it’s rating to Mkt Perform. H.C. Wainwright downgraded its rating to a Neutral. Robert W. Baird initiated its recommendation with a Outperform and recommended $50 as its price target on September 09, 2021. H.C. Wainwright upgraded its rating to Buy for this stock on August 04, 2021, but kept the price target unchanged to $100. In a note dated April 05, 2021, H.C. Wainwright downgraded an Neutral rating on this stock.
BeyondSpring Inc [BYSI] stock has fluctuated between $0.65 and $4.00 over the past year. BeyondSpring Inc [NASDAQ: BYSI] shares were valued at $3.57 at the most recent close of the market.
Analyzing the BYSI fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -24.34%, Pretax Profit Margin comes in at -24.06%, and Net Profit Margin reading is -21.91%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.39 points at the first support level, and at 3.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.68, and for the 2nd resistance point, it is at 3.79.
BeyondSpring Inc [BYSI] reported earnings per share of -$0.24 for its fiscal quarter that ended on 12/30/2021. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.26/share, meaning a difference of $0.02 and a surprise factor of 7.70%. By comparison, the stated earnings for the previous quarter ended on 9/29/2021 were -$0.47 per share as compared to estimates of -$0.37 per share, a difference of -$0.1 representing a surprise of -27.00%.
Ratios To Look Out For
For context, BeyondSpring Inc’s Current Ratio is 3.78. In addition, the Quick Ratio stands at 3.78.
